![Life | Free Full-Text | BiTEs, DARTS, BiKEs and TriKEs—Are Antibody Based Therapies Changing the Future Treatment of AML? Life | Free Full-Text | BiTEs, DARTS, BiKEs and TriKEs—Are Antibody Based Therapies Changing the Future Treatment of AML?](https://pub.mdpi-res.com/life/life-11-00465/article_deploy/html/images/life-11-00465-g001.png?1621770654)
Life | Free Full-Text | BiTEs, DARTS, BiKEs and TriKEs—Are Antibody Based Therapies Changing the Future Treatment of AML?
Fn14-Directed DART Nanoparticles Selectively Target Neoplastic Cells in Preclinical Models of Triple-Negative Breast Cancer Brain Metastasis | Molecular Pharmaceutics
![A guide to cancer immunotherapy: from T cell basic science to clinical practice | Nature Reviews Immunology A guide to cancer immunotherapy: from T cell basic science to clinical practice | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-020-0306-5/MediaObjects/41577_2020_306_Fig1_HTML.png)
A guide to cancer immunotherapy: from T cell basic science to clinical practice | Nature Reviews Immunology
![Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 Blockade - ScienceDirect Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 Blockade - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0360301622031881-gr1.jpg)
Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 Blockade - ScienceDirect
![Frontiers | Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART® Molecules Frontiers | Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART® Molecules](https://www.frontiersin.org/files/Articles/710273/fimmu-12-710273-HTML-r1/image_m/fimmu-12-710273-g001.jpg)
Frontiers | Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART® Molecules
![In Vivo Tracking of Chimeric Antigen Receptor T-Cells | Stanford Cancer Institute | Stanford Medicine In Vivo Tracking of Chimeric Antigen Receptor T-Cells | Stanford Cancer Institute | Stanford Medicine](https://med.stanford.edu/cancer/about/news/CART-cell-trackers/_jcr_content/main/simple_banner.img.620.high.jpg/bulls-eye.jpg)
In Vivo Tracking of Chimeric Antigen Receptor T-Cells | Stanford Cancer Institute | Stanford Medicine
![JCI - Dual-Affinity Re-Targeting proteins direct T cell–mediated cytolysis of latently HIV-infected cells JCI - Dual-Affinity Re-Targeting proteins direct T cell–mediated cytolysis of latently HIV-infected cells](https://dm5migu4zj3pb.cloudfront.net/manuscripts/82000/82314/medium/JCI82314.f1.jpg)
JCI - Dual-Affinity Re-Targeting proteins direct T cell–mediated cytolysis of latently HIV-infected cells
![soria on X: "T cell-engaging therapies: BITE, CITE, DART, TRIK, SMITE,... a whole #immunotherapy world https://t.co/SDtxZ5RVWv https://t.co/da4J4QQWtn" / X soria on X: "T cell-engaging therapies: BITE, CITE, DART, TRIK, SMITE,... a whole #immunotherapy world https://t.co/SDtxZ5RVWv https://t.co/da4J4QQWtn" / X](https://pbs.twimg.com/media/EbIw_lyXQAAF2Zi.png)
soria on X: "T cell-engaging therapies: BITE, CITE, DART, TRIK, SMITE,... a whole #immunotherapy world https://t.co/SDtxZ5RVWv https://t.co/da4J4QQWtn" / X
![SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers | Clearity Foundation SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers | Clearity Foundation](https://www.clearityfoundation.org/wp-content/uploads/2023/04/image-1.png)
SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers | Clearity Foundation
![Cancers | Free Full-Text | Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia Cancers | Free Full-Text | Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia](https://www.mdpi.com/cancers/cancers-13-06246/article_deploy/html/images/cancers-13-06246-g001.png)
Cancers | Free Full-Text | Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia
![Bispecific antibodies: BiTE, DARTs, and TandAbs (Part 15- mAbs) | by Roohi Bansal | Biotechnology by TSB | Medium Bispecific antibodies: BiTE, DARTs, and TandAbs (Part 15- mAbs) | by Roohi Bansal | Biotechnology by TSB | Medium](https://miro.medium.com/v2/resize:fit:1400/1*_bn0nrmxeXOXtZCO-W66IQ.png)